Northern Trust’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,059
| Closed | -$6.26K | – | 4453 |
|
|
2024
Q2 | $6.26K | Sell |
1,059
-5
| -0.5% | -$30 | ﹤0.01% | 4401 |
|
|
2024
Q1 | $12.5K | Hold |
1,064
| – | – | ﹤0.01% | 4374 |
|
|
2023
Q4 | $11.4K | Hold |
1,064
| – | – | ﹤0.01% | 4412 |
|
|
2023
Q3 | $14.3K | Hold |
1,064
| – | – | ﹤0.01% | 4370 |
|
|
2023
Q2 | $26.6K | Sell |
1,064
-364
| -25% | -$9.1K | ﹤0.01% | 4349 |
|
|
2023
Q1 | $24.9K | Hold |
1,428
| – | – | ﹤0.01% | 4407 |
|
|
2022
Q4 | $16.2K | Hold |
1,428
| – | – | ﹤0.01% | 4523 |
|
|
2022
Q3 | $35K | Buy |
1,428
+105
| +8% | +$2.57K | ﹤0.01% | 4421 |
|
|
2022
Q2 | $70K | Sell |
1,323
-23
| -2% | -$1.22K | ﹤0.01% | 4303 |
|
|
2022
Q1 | $96K | Buy |
1,346
+364
| +37% | +$26K | ﹤0.01% | 4351 |
|
|
2021
Q4 | $67K | Hold |
982
| – | – | ﹤0.01% | 4538 |
|
|
2021
Q3 | $113K | Hold |
982
| – | – | ﹤0.01% | 4371 |
|
|
2021
Q2 | $148K | Sell |
982
-4
| -0.4% | -$603 | ﹤0.01% | 4252 |
|
|
2021
Q1 | $168K | Buy |
986
+931
| +1,693% | +$159K | ﹤0.01% | 4155 |
|
|
2020
Q4 | $5K | Sell |
55
-59
| -52% | -$5.36K | ﹤0.01% | 4362 |
|
|
2020
Q3 | $14K | Buy |
114
+32
| +39% | +$3.93K | ﹤0.01% | 4245 |
|
|
2020
Q2 | $11K | Hold |
82
| – | – | ﹤0.01% | 4211 |
|
|
2020
Q1 | $7K | Buy |
+82
| New | +$7K | ﹤0.01% | 4174 |
|
|
2018
Q3 | – | Sell |
-20
| Closed | -$41K | – | 4334 |
|
|
2018
Q2 | $41K | Hold |
20
| – | – | ﹤0.01% | 4144 |
|
|
2018
Q1 | $55K | Hold |
20
| – | – | ﹤0.01% | 4067 |
|
|
2017
Q4 | $87K | Hold |
20
| – | – | ﹤0.01% | 3997 |
|
|
2017
Q3 | $161K | Hold |
20
| – | – | ﹤0.01% | 3850 |
|
|
2017
Q2 | $97K | Sell |
20
-96
| -83% | -$466K | ﹤0.01% | 3984 |
|
|
2017
Q1 | $642K | Buy |
116
+8
| +7% | +$44.3K | ﹤0.01% | 3476 |
|
|
2016
Q4 | $722K | Buy |
108
+13
| +14% | +$86.9K | ﹤0.01% | 3434 |
|
|
2016
Q3 | $1.44M | Buy |
95
+1
| +1% | +$15.1K | ﹤0.01% | 3219 |
|
|
2016
Q2 | $1.48M | Buy |
94
+81
| +623% | +$1.28M | ﹤0.01% | 3189 |
|
|
2016
Q1 | $267K | Buy |
13
+1
| +8% | +$20.5K | ﹤0.01% | 3636 |
|
|
2015
Q4 | $247K | Hold |
12
| – | – | ﹤0.01% | 3696 |
|
|
2015
Q3 | $245K | Buy |
12
+3
| +33% | +$61.3K | ﹤0.01% | 3676 |
|
|
2015
Q2 | $229K | Sell |
9
-2
| -18% | -$50.9K | ﹤0.01% | 3754 |
|
|
2015
Q1 | $211K | Buy |
11
+4
| +57% | +$76.7K | ﹤0.01% | 3853 |
|
|
2014
Q4 | $86K | Hold |
7
| – | – | ﹤0.01% | 4002 |
|
|
2014
Q3 | $105K | Hold |
7
| – | – | ﹤0.01% | 4009 |
|
|
2014
Q2 | $102K | Hold |
7
| – | – | ﹤0.01% | 4007 |
|
|
2014
Q1 | $151K | Buy |
7
+2
| +40% | +$43.1K | ﹤0.01% | 3853 |
|
|
2013
Q4 | $69K | Buy |
5
+1
| +25% | +$13.8K | ﹤0.01% | 3932 |
|
|
2013
Q3 | $59K | Hold |
4
| – | – | ﹤0.01% | 3912 |
|
|
2013
Q2 | $60K | Buy |
+4
| New | +$60K | ﹤0.01% | 3899 |
|